• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anika Therapeutics Inc

+ Add to Watchlist

AKP:GR

30.732 EUR 1.190 4.03%

As of 02:05:21 ET on 12/18/2014.

Snapshot for Anika Therapeutics Inc (AKP)

Open: 30.746 Day's Range: 30.732 - 30.746 Volume: 0
Previous Close: 29.542 52wk Range: 21.200 - 38.095 1-Yr Rtn: +23.50%

Stock Chart for AKP

No chart data available.
  • AKP:GR 30.732
  • 1D
  • 1M
  • 1Y
29.542
Interactive AKP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.0630
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.5050
Est. PEG Ratio 0.5021
Market Cap (M EUR) 445.74
Shares Outstanding (M) 14.50
30 Day Average Volume 19
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKP

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Frank J LuppinoChief Operating OfficerEdward S AhnChief Technology & Strategy Ofcr
More Company Profile & Key Executives for AKP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil